Literature DB >> 10889003

Audiovestibular phenotype associated with a COL11A1 mutation in Marshall syndrome.

A J Griffith1, S S Gebarski, N T Shepard, P R Kileny.   

Abstract

BACKGROUND: Marshall syndrome is a dominant disorder characterized by craniofacial and skeletal abnormalities, sensorineural hearing loss, myopia, and cataracts, and is associated with splicing mutations in COL11A1.
OBJECTIVE: To determine the auditory and vestibular phenotypes associated with a COL11A1 splicing.
DESIGN: Clinical otolaryngologic, audiologic, vestibular, and radiologic evaluations of the auditory and vestibular systems.
SUBJECTS: Three affected individuals from a family cosegregating Marshall syndrome and a COL11A1 splice site mutation.
RESULTS: The study subjects have progressive sensorineural hearing loss that is predominantly cochlear in origin and asymptomatic dysfunction of the central and peripheral vestibular systems. Computed tomography detected no malformations of temporal bone structures.
CONCLUSIONS: The observed auditory and vestibular abnormalities are not caused by defective morphogenesis of the osseous labyrinth, but by more direct effects of the COL11A1 mutation on the membranous labyrinth and the central nervous system. The onset and degree of hearing loss associated with COL11A1 mutations are useful clinical features to differentiate Marshall syndrome from the phenotypically similar Stickler syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 10889003     DOI: 10.1001/archotol.126.7.891

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  6 in total

1.  Characterization of an abundant COL9A1 transcript in the cochlea with a novel 3' UTR: Expression studies and detection of miRNA target sequence.

Authors:  Theru A Sivakumaran; Barbara L Resendes; Nahid G Robertson; Anne B S Giersch; Cynthia C Morton
Journal:  J Assoc Res Otolaryngol       Date:  2006-04-19

Review 2.  Hearing Loss in Stickler Syndrome: An Update.

Authors:  Frederic R E Acke; Els M R De Leenheer
Journal:  Genes (Basel)       Date:  2022-09-01       Impact factor: 4.141

3.  Inhibition of the Pim1 oncogene results in diminished visual function.

Authors:  Jun Yin; Lisa Shine; Francis Raycroft; Sudhakar Deeti; Alison Reynolds; Kristin M Ackerman; Antonino Glaviano; Sean O'Farrell; Olivia O'Leary; Claire Kilty; Ciaran Kennedy; Sarah McLoughlin; Megan Rice; Eileen Russell; Desmond G Higgins; David R Hyde; Breandan N Kennedy
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

4.  Development and clinical utility of a novel diagnostic nystagmus gene panel using targeted next-generation sequencing.

Authors:  Mervyn G Thomas; Gail DE Maconachie; Viral Sheth; Rebecca J McLean; Irene Gottlob
Journal:  Eur J Hum Genet       Date:  2017-04-05       Impact factor: 4.246

5.  Splice-altering variant in COL11A1 as a cause of nonsyndromic hearing loss DFNA37.

Authors:  Kevin T Booth; James W Askew; Zohreh Talebizadeh; Patrick L M Huygen; James Eudy; Judith Kenyon; Denise Hoover; Michael S Hildebrand; Katherine R Smith; Melanie Bahlo; William J Kimberling; Richard J H Smith; Hela Azaiez; Shelley D Smith
Journal:  Genet Med       Date:  2018-09-24       Impact factor: 8.822

6.  Targeted Deletion of Loxl3 by Col2a1-Cre Leads to Progressive Hearing Loss.

Authors:  Ziyi Liu; Xinfeng Bai; Peifeng Wan; Fan Mo; Ge Chen; Jian Zhang; Jiangang Gao
Journal:  Front Cell Dev Biol       Date:  2021-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.